The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Entero Therapeutics Inc’s stock clocked out at $0.42, down -1.33% from its previous closing price of $0.43. In other words, the price has decreased by -$1.33 from its previous closing price. On the day, 0.72 million shares were traded.
Ratios:
To gain a deeper understanding of ENTO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.90 and its Current Ratio is at 2.90. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 06 ’25 when Romano Sarah sold 727 shares for $0.64 per share. The transaction valued at 465 led to the insider holds 17,287 shares of the business.
Romano Sarah sold 476 shares of ENTO for $212 on Oct 09 ’24. The Chief Financial Officer now owns 18,014 shares after completing the transaction at $0.45 per share. On Jul 02 ’24, another insider, Romano Sarah, who serves as the Chief Financial Officer of the company, sold 621 shares for $1.07 each. As a result, the insider received 664 and left with 18,490 shares of the company.
Stock Price History:
Over the past 52 weeks, ENTO has reached a high of $3.16, while it has fallen to a 52-week low of $0.19. The 50-Day Moving Average of the stock is -3.45%, while the 200-Day Moving Average is calculated to be -13.57%.
Shares Statistics:
A total of 4.77M shares are outstanding, with a floating share count of 4.67M. Insiders hold about 1.97% of the company’s shares, while institutions hold 2.97% stake in the company.
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
